Figure 2.
Type I and type II error probabilities according to the true level of effectiveness (% risk reduction vs. placebo) in the active-control arm. Rates are for a hypothetical NI trial with NI-margin=1.3, effect size versus active-control=0.7, sample size = 110 events, and planned active-control effectiveness=50%.